Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Bests Annual Novel Drug Approval Record With Four Oks In One Week

Dec 22 2017

• By Michael Cipriano and Joseph Haas

2017 Celebration_ 426864196 _1200.jpg

Related Content

Keeping Track Of Novel Agents: US FDA Approves Nerlynx And Vosevi, Turns Down Evenity; Macrilen Returns

Jul 24 2017

FDA's Gottlieb Pushing 'Seamless' Clinical Trials For Faster Development

Sep 12 2017

Aerie's Netarsudil Headed For Broad Indication With Only Subpopulation Efficacy

Oct 15 2017

Aerie's Netarsudil's Safety Questions May Determine Fate At Advisory Committee

Oct 12 2017

Phase III Data For La Jolla's Angiotensin II Drug Leave Questions About Clinical Benefit

May 22 2017

Keeping Track: US FDA Approves Siliq, Accepts Mylan/Biocon Pegfilgrastim Biosimilar

Feb 18 2017

Aerie's Rhopressa Approved Early For Glaucoma, 2018 Launch Planned

Dec 20 2017

Merck & Co, Pfizer Ertugliflozin Combo Data Beef Up Profile

Jun 12 2017

Related Companies

La Jolla Pharmaceutical Company

Aerie Pharmaceuticals, Inc.

COSCIENS Biopharma

Merck & Co., Inc.

Pfizer Inc.

Johnson & Johnson

AstraZeneca PLC

Eli Lilly and Company

Boehringer Ingelheim GmbH

Medimetriks Pharmaceuticals, Inc.

Additional Topics

United States Approvals FDA Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.